Lincoln Pharmaceuticals, an Indian pharmaceutical company based in Gujarat. It is a public limited company listed on NSE and BSE. It was founded by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel in 1979. Lincoln Pharmaceuticals is a leading name in the pharmaceutical industry. Currently it is a globally recognized pharmaceutical manufacturer, exporting to over 70 countries. It has six marketing units & more than 2300 employees.

In order to help people live better lives, Lincoln Pharmaceuticals creates and manufactures medicines that are both innovative and cheap. The organization has created more than 600 formulations in 15 different therapeutic areas, and it possesses a robust product and brand portfolio in a variety of therapeutic areas, including anti-infective, respiratory system, gynaecology, cardiac and central nervous system, anti-bacterial, anti-diabetic, and anti-malaria. Within the company, there are approximately 1,700 registered items, and another 700 are in the pipeline. Additionally, the company exports to more than sixty countries, in addition to having a significant presence in the domestic market, where it has a solid strength of its own field force. 

  
Lincoln Pharmaceuticals provides a range of pharmaceutical products that cater to various therapeutic segments. These include: Anti-Malarial, Anti-Bacterial, Anti-Fungal, Anti-Tuberculosis, Pain Management, Gynaecology, Anesthesia, Cardiac & Diabetic Care, Vitamin & Nutritional Supplements. The company offers effective treatments for tuberculosis, a persistent health challenge in many developing countries.

Lincoln Pharmaceuticals was awarded WHO cGMP (The World Health Organization for adhering to Good Manufacturing Practices) in 1984. The company has two manufacturing facilities in the cities of Ahmedabad and Mehsana in the state of Gujarat that are certified by ISO 9001:2015.

History and Evolution
Lincoln Pharmaceuticals Limited was founded in 1979 by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel in Gujarat, with a vision to provide affordable and high-quality healthcare solutions. Over the decades, the company has continuously evolved, embracing new technologies and methodologies to enhance its product offerings and manufacturing processes.

The initial public offering of the company took place in 1996, and it was simultaneously listed on the Bombay Stock Exchange. In the year 2000, the corporation has covered eighty percent of the domestic market in India. 2010-2011 saw the introduction of three new NDDS products by the company.

On February 15, 2015, Lincoln Pharmaceuticals became a Limited company and listed on the National Stock Exchange of India under the ticker symbol "LINCOLN".

Manufacturing Capabilities
Lincoln Pharmaceuticals has two manufacturing facilities one located in Ahmedabad, while the other is located in Mehsana. Both of these plants are outfitted with cutting-edge machinery and technology. Company’s manufacturing facilities comply with stringent international quality and compliance norms and certified by EUGMP, TGA, WHO-GMP; ISO-9001:2015, ISO-14001:2015 and ISO-45001:2018. Company is engaged in manufacturing of pharma formulations like Tablets, Capsules, Injectables, Syrups, Ointments, etc. Lincoln Pharmaceuticals is well-known for its manufacturing facilities, which are noted for their cutting-edge sophistication and their adherence to high quality standards and regulatory regulations. It is the responsibility of international regulatory agencies to certify these facilities, which guarantees that all goods are in accordance with worldwide standards of safety and effectiveness. 

Research and Development
Lincoln Pharmaceuticals possesses a robust Research and Development (R&D) team including more than 30 scientists. It has submitted over 25 patent applications and has been granted seven patents. The company's R&D center has been acknowledged by the Department of Scientific and Technology, Government of India. It is equipped with advanced instruments and equipment for conducting internal physical, chemical, and microbiological analysis of all products.

The company invests significantly in research and development (R&D) to discover new drugs and improve existing formulations. Their R&D team comprises experienced scientists and researchers dedicated to finding solutions to unmet medical needs. This focus on innovation has led to several patents and proprietary technologies, positioning Lincoln Pharmaceuticals as a leader in the industry.

Global Presence
Lincoln Pharmaceuticals has built a presence in over sixty countries across the continents of Asia, Africa, Latin America, and Europe thanks to its robust export network for the pharmaceutical industry. The international strategy of the company involves the formation of strategic partnerships, the adherence to the regulatory requirements of various regions, and the customization of products to be in accordance with the requirements of the local market.

The European Union (EU) GMP from EudraGMP, the Therapeutic Goods Administration (TGA) in Australia, and more than 60 other country's drug authorities have all authorized Lincoln's production facility.

Quality Control
The operations of Lincoln Pharmaceuticals are held to a standard of quality that cannot be compromised. The business adheres to industry standards known as Good Manufacturing Practices (GMP) and has been awarded certifications from a number of different international health authorities. Each and every product that leaves the factory is guaranteed to be risk-free, efficient, and dependable thanks to their stringent quality control procedures.

Social Responsibility
Lincoln Pharmaceuticals is committed to giving back to the community and has launched a number of programs that are centered on matters pertaining to social welfare, education, and healthcare. Through its corporate social responsibility (CSR) initiatives, the corporation seeks to enhance the standard of living in disadvantaged communities and to advance sustainable development.

In addition to two windmills, the company has also established a new Solar Plant with a capacity of 1 MW on the rooftop of its facility. By generating renewable energy, we are able to meet 65% of our energy needs, resulting in substantial savings in electricity costs and enabling our company to become self-sustainable and environmentally friendly.

Among the companies that operate in the pharmaceutical sector, Lincoln Pharmaceuticals Limited is a shining example of the spirit of innovation, excellence, and commitment. From the time it was founded until it reached its current position as a global player, the path of the organization is a demonstration of its commitment to enhancing the quality of healthcare outcomes all over the world. The aim of Lincoln Pharmaceuticals, which is to make healthcare solutions available to everyone at prices that are affordable and accessible, is the company's primary focus as it continues to expand and develop.